Sowilo India Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2018.
2018 Delhi, Delhi, India Active
Last Updated:
Access Report
About Sowilo India Pharmaceuticals Private Limited

Sowilo India Pharmaceuticals Private Limited, a active private limited company, was established on 17 October 2018 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51909DL2018PTC340658. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.15 M.

Employing 30 professional, Its leadership includes Savita Tiwari (Director), Poonam Srivastava (Director), Tripti Shukla (Director). It holds ₹6.07 M open charges and no settled loans. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No-27/110/2 Gali No-6,Block-E West Karawal Nagar, Delhi, Delhi, 110094.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909DL2018PTC340658

  • Registration Number

    340658

  • Incorporation Date

    17 October 2018

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 7 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 6.07 M
  • Revenue Growth **** 48.05%
  • Profit Growth **** 138.69%
  • Ebitda **** 44.67%
  • Net Worth 87.99%
  • Total Assets **** 42.38%
Company report

Sowilo India Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Sowilo India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sowilo India Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Savita Tiwari Director 17 Oct 2018 Current
Poonam Srivastava Director 17 Oct 2018 Current
Tripti Shukla Director 11 Jun 2021 Current
Jatin Trivedi Director 13 Aug 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sowilo India Pharmaceuticals.

Sowilo India Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.05% increase. The company also saw a substantial improvement in profitability, with a 138.69% increase in profit. The company's net worth Soared by an impressive increase of 87.99%.

Sowilo India Pharmaceuticals revenue growth over time
Sowilo India Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 48.05%
*******
*******
*******
*******
Revenue from Operations
*******
 48.05%
*******
*******
*******
*******
Total Assets
*******
 42.38%
*******
*******
*******
*******
Profit or Loss
*******
 138.69%
*******
*******
*******
*******
Net Worth
*******
 87.99%
*******
*******
*******
*******
EBITDA
*******
 44.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sowilo India Pharmaceuticals?

In 2023, Sowilo India Pharmaceuticals had a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹6,068,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.61 Cr
Latest Charge Details
Date Lender Amount Status
31 Dec 2024 Hdfc Bank Limited ₹2.19 M Open
06 Jul 2023 Hdfc Bank Limited ₹2.50 M Open
30 Apr 2021 Hdfc Bank Limited ₹1.38 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Sowilo India Pharmaceuticals?

Sowilo India Pharmaceuticals has a workforce of 30 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sowilo India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sowilo India Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sowilo India Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.19 M with Charge ID 101053533 was registered on 31 Dec 2024. was recorded as a recent event.

  • Annual General Meeting

    The activity Sowilo India Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Sowilo India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 100751743 was registered on 06 Jul 2023. was documented.

  • Director Appointment

    Progress on Tripti Shukla was appointed as a Director was appointed as a Director on 11 Jun 2021 & has been associated with this company since 4 years 11 months . was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 1.38 M with Charge ID 100455491 was registered on 30 Apr 2021. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sowilo India Pharmaceuticals Private Limited?

The CIN of Sowilo India Pharmaceuticals Private Limited is U51909DL2018PTC340658.

Where is Sowilo India Pharmaceuticals Private Limited headquartered?

Sowilo India Pharmaceuticals Private Limited is headquartered at H.No-27/110/2 Gali No-6,Block-E West Karawal Nagar, Delhi, Delhi, 110094.

When was Sowilo India Pharmaceuticals Private Limited incorporated?

Sowilo India Pharmaceuticals Private Limited was incorporated on 17 October 2018.

Who are the current directors of Sowilo India Pharmaceuticals Private Limited?

The current directors of Sowilo India Pharmaceuticals Private Limited are

What is the primary industry of Sowilo India Pharmaceuticals Private Limited?

The primary industry of Sowilo India Pharmaceuticals Private Limited is Manufacturing.

Is Sowilo India Pharmaceuticals Private Limited a listed company?

Sowilo India Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sowilo India Pharmaceuticals Private Limited?

The authorized capital of Sowilo India Pharmaceuticals Private Limited is ₹0.20 M, and the paid-up capital is ₹0.15 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available